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We report for the ﬁrst time abnormalities in cardiac ventricular electrophysiology in a genetically
modiﬁed murine model lacking the Scn3b gene (Scn3b/). Scn3b/ mice were created by homologous
recombination in embryonic stem (ES) cells. RT-PCR analysis conﬁrmed that Scn3b mRNA was expressed
in the ventricles of wild-type (WT) hearts but was absent in the Scn3b/ hearts. These hearts also
showed increased expression levels of Scn1b mRNA in both ventricles and Scn5a mRNA in the right
ventricles compared to ﬁndings in WT hearts. Scn1b and Scn5a mRNA was expressed at higher levels in
the left than in the right ventricles of both Scn3b/ and WT hearts. Bipolar electrogram and monophasic
action potential recordings from the ventricles of Langendorff-perfused Scn3b/ hearts demonstrated
signiﬁcantly shorter ventricular effective refractory periods (VERPs), larger ratios of electrogram duration
obtained at the shortest and longest S1–S2 intervals, and ventricular tachycardias (VTs) induced by
programmed electrical stimulation. Such arrhythmogenesis took the form of either monomorphic or
polymorphic VT. Despite shorter action potential durations (APDs) in both the endocardium and
epicardium, Scn3b/ hearts showed DAPD90 values that remained similar to those shown in WT hearts.
The whole-cell patch-clamp technique applied to ventricular myocytes isolated from Scn3b/ hearts
demonstrated reduced peak Naþ current densities and inactivation curves that were shifted in the
negative direction, relative to those shown in WT myocytes. Together, these ﬁndings associate the lack of
the Scn3b gene with arrhythmic tendencies in intact perfused hearts and electrophysiological features
similar to those in Scn5aþ/ hearts.
 2009 Elsevier Ltd.Open access under CC BY license.Contents
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Voltage-gated sodium (Naþ) channels, critical for the excitation
of cardiac muscle (Keating and Sanguinetti, 2001), are formed of
pore-forming a-subunits and one or more b-subunits (Isom, 2001).
Experiments using the two-electrode voltage clamp in Xenopus
oocytes demonstrated that the a-subunits alone can form func-
tional Naþ channels (Noda et al., 1986). Thus far nine a-subunits,
Nav1.1–Nav1.9 are each encoded by different genes and have been
identiﬁed and cloned in mammals. Mutations in SCN5A which
encodes for the cardiac a-subunit, Nav1.5, can result in arrhythmic
conditions, including the Brugada (BrS) and Long QT syndrome
(LQTS) (Tan et al., 2003).
However, the electrophysiological roles of b-subunits in the
function of cardiac Naþ channels are less well understood. Six
b-subunits have been identiﬁed and are encoded by 4 different
genes; SCN1B, SCN2B, SCN3B and SCN4B (Isom et al., 1992, 1995a;
Kazen-Gillespie et al., 2000; Morgan et al., 2000; Qin et al., 2003;
Yu et al., 2003). These genes, which encode for b1, b2, b3 and b4
subunits respectively, are expressed in human tissues including
the brain, skeletal muscle and the heart (Candenas et al., 2006;
Stevens et al., 2001). Of these, the b1 and b3 subunits have been
demonstrated in the transverse tubules, and b2 and b4 subunits in
the intercalated disks of murine ventricular myocytes (Maier
et al., 2004).
It is possible that the presence of b-subunits can affect both the
function and expression of the Naþ channel. Firstly, studies in
heterologous expression systems provided by Xenopus oocytes,
Chinese hamster ovary (CHO) cells and human embryonic kidney
(HEK) cells demonstrated that b-subunits modify gating kinetics,
including activation, inactivation and the recovery from inactiva-
tion of the Naþ channel (Chen et al., 2002; Meadows et al., 2002;
Morgan et al., 2000; Patton et al., 1994). However, these alterations
vary with the particular cell types used to express the Naþ channel
subunits (Isom et al., 1995b; Morgan et al., 2000; Qu et al., 2001).
Secondly, these subunits can also alter the Naþ current amplitude
(Fahmi et al., 2001; Lopez-Santiago et al., 2007; Watanabe et al.,
2008). Thirdly, b-subunits contain domains that are structurally
homologous to the V-set of the Ig superfamily, which includes cell
adhesion molecules (CAMs) (Isom et al., 1995a). This permits cell–
cell interaction and adhesion in cells expressing these subunits
(Malhotra et al., 2000). Finally, the b-subunits have been shown to
regulate the expression density of the Naþ channel in the plasma
membrane. Experiments using CHO and 1610 cell lines have
demonstrated a 2- to 4-fold greater Naþ channel expression when
a-subunits were co-expressed with b1 subunits, than when these
were expressed alone (Isom et al., 1995b).
The presence or absence of b-subunits has recently been asso-
ciated with electrophysiological abnormalities in cardiac tissue.
Surface electrocardiogram experiments carried out on genetically
modiﬁed mice, lacking the Scn1b gene, have demonstrated a LQT-
like phenotype, characterised by a prolonged QT interval (Lopez-Santiago et al., 2007). However, only two clinical reports thus far
have associated mutations in the gene SCN4Bwith LQTS (Medeiros-
Domingo et al., 2007) and SCN1B, encoding both b1 and b1B subunits
with BrS (Watanabe et al., 2008). In the present study, we assessed,
for the ﬁrst time, electrophysiological properties in the ventricles of
Scn3b/ hearts compared to those shown in WT hearts. Firstly,
Scn3b/ mice were created using homologous recombination in
embryonic stem (ES) cells. The phenotype of the resulting Scn3b/
mice, including body weight and temperature, appeared similar to
that of WT mice. Secondly, ventricles of such mice showed altered
expression levels of Scn3b, Scn1b and Scn5amRNA. Thirdly, studies
in Langendorff-perfused Scn3b/ hearts demonstrated arrhyth-
mogenic features. Finally, these corresponded to changes in the
biophysical properties of the Naþ channel, with features similar to
those previously reported in Scn5aþ/ hearts (Papadatos et al.,
2002; Stokoe et al., 2007a).
2. Methods
2.1. Generation of Scn3b-deﬁcient (/) mice
PCR ampliﬁcation was used to generate homologous arms from
the 129SvEv mouse genome, using primers designed to amplify a 50
arm spanning 2.0 kb of the Scn3b locus terminating downstream of
the third coding exon splice acceptor (50armF; tttgcggc
cgCAGCCTTGTATGAACCCAGGGTCTTTC and 50armR; tttactagt
CACCTCCTGGTGGCCATTTCGATACTC) and a 30 arm spanning 4.1 kb
of the Scn3b locus commencing just upstream of the third coding
exon splice donor (30armF; tttggcgcgccGGTAAGCCTGAGGCCTGTAG
TCTCTTC and 30armR; tttggccggccGTGGACTTTAGTCCCATGTCCTC
ATTG).
The arms were cloned into the plasmid pTK5IBLMNL (Paradigm
Therapeutics Ltd, Cambridge, U.K.) using the restriction sites
incorporated in the arm primers, such that the 50 and 30 arms ﬂank
an IRES-fronted LacZ reporter gene followed by a loxP-ﬂanked
PGKNeopA selectable marker. After homologous recombination,
191 bp of the 226 bp third coding exon is replaced by the IRESLacZ/
PGKneo cassette. Putative targeted embryonic stem (ES) cells were
identiﬁed by PCR using an external 50 screening primer (50scr:
CTGACATCTTCTCAGCAGATAACTGAC) in combination with a vector
speciﬁc primer (DR2; ATCATGGCCCTACCATGCGCTAAACAC).
Successfully targeted ES cells were further conﬁrmed by Southern
blot of AﬂII and BclI digested genomic DNA, using an external probe
ampliﬁed from a genomic region downstream of the end of the 30
arm (using the primers 30prF; AGATGTCCAGCGATACTGTTGAGGCAG
and 30prR; TGTGAGTCTTATTGGAGGTACAGTGTG), indicating that
the integration had occurred legitimately.
Correctly targeted 129 SvEv ES cells, containing the Scn3b
knockout (KO) allele were injected into host blastocysts as previ-
ously described (Bradley et al., 1984), generating male chimeras
which were subsequently mated with 129 SvEv females. Pups from
these crosses were screened with the original target screening PCR
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gote animals and in further generations by a multiplex PCR
designed to amplify a 204 bp region speciﬁc to the WT allele and
a 334 bp region speciﬁc to the Scn3b KO allele. This allowed
differentiation of each of the three possible genotypes (using
primers hetF, GTCGTCTGCAGTGGAATGGGAGCAAAG; hetR, TGA
AGAGACTACAGGCCTCAGGCTTAC; and Asc306, AATGGCCGCTTT
TCTGGATTCATCGAC). All genotypes were observed at the expected
Mendelian ratios. Routinely homozygous matings were established
to produce the experimental cohorts and 129SvEv stock used as the
WT controls. Male and female offspring of WT and Scn3b/ mice
were randomly selected for use in all experiments. Mice obtained
were kept in cages at a room temperature of 211 C in an animal
facility with 12-hour light/dark cycles. The mice had free access to
sterile rodent chow and water.
A series of tests were used to assess baseline metabolic and
behavioural parameters and were performed on cohorts of WT
and Scn3b/ mice. Each cohort typically consisted of 5–8 mice
of either sex at the age of 3–4 months. The metabolic tests
included measuring the body weight and temperature. Each
mouse was weighed monthly for up to 3 months and body
temperature was measured using a rectal probe (World Precision
Instruments, Florida, USA). The behavioural tests measured
visual tracking, locomotor activity, touch sensitivity and anxiety.
Firstly, visual tracking was assessed using an optokinetic drum
apparatus (Paradigm Therapeutics, Cambridge, U.K.). Secondly,
locomotor activity was measured as the distance travelled, in
one hour, using the LABORAS system (Metris, Hoofddorp, The
Netherlands). Finally, the percentage time spent in the open and
closed arms of an elevated plus-maze apparatus was used to
assess aversion to open spaces in the mice (Lister, 1987). All
procedures conformed to the UK Animals (Scientiﬁc Procedures)
Act 1986.
Randomly selected male and female mice (age 5–8 months)
were killed by cervical dislocation in all RT-PCR and ex vivo
experiments (Schedule 1: UK Animals (Scientiﬁc Procedures) Act
1986).
2.2. Analysis of sodium channel a- and b-subunit transcripts
To quantify changes in the mRNA expression levels of sodium a-
and b-subunits in hearts obtained from WT and Scn3b/ mice,
RT-PCR experiments were performed on an ABI 7500 Fast cycler
(Applied Biosystems, Warrington, U.K.). Total RNA was isolated
from left atria (LA), right atria (RA), left ventricle (LV) and right
ventricle (RV) of WT and Scn3b/mice (n¼ 3 each) using a Qiagen
RNAeasy kit. Excised tissues were stored in RNAlater (Ambion,
Warrington, U.K.) to maintain the integrity of the RNA before
isolation. The total RNA was reverse transcribed into cDNA using
random hexamer primers and a SuperScript III kit (Invitrogen,
Paisley, U.K.). Oligos for Scn3b, Scn5a, and Scn1bwere FAM/TAMRA
labelled (Applied Biosystems). All experiments were performed in
triplicate.
The number of the copies of mRNA was calculated from its
respective threshold cycle (CT) using a standard curve. Each value
was normalized for the expression value of the housekeeper gene,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and
expressed as a percentage of GAPDH expression (i.e. 2DCT 100).
2.3. Preparation of Langendorff-perfused hearts for
electrophysiological recordings
The experiments used Langendorff-perfused murine hearts as
previously described (Balasubramaniam et al., 2003). Hearts were
rapidly excised whilst minimizing contact with the atria andventricles, then submerged in ice-cold bicarbonate-buffered Krebs–
Henseleit solution containing (mM): 119 NaCl, 25 NaHCO3, 4.0 KCl,
1.2 KH2PO4, 1.0 MgCl2, 1.8 CaCl2, 10 glucose and 2.0 sodium-pyru-
vate (pH 7.4) and bubbled with 95% O2/5% CO2 gas mixture (British
Oxygen Company, Manchester, U.K.). Under the ice-cold buffer,
excess tissues surrounding the heart were removed, leaving
a 2–3 mm section of the aorta. This was cannulated and sealed,
using a micro-aneurysm clip (Harvard Apparatus, Edenbridge, U.K.)
to a 21-gauge tailor-made cannula. The latter was pre-ﬁlled with
ice-cold buffer solution using a 1 ml syringe. The preparation was
transferred and attached to a Langendorff system, and then retro-
gradely perfused, using the bicarbonate-buffered Krebs–Henseleit
solution described above, warmed to 37 C via a water jacket and
circulator (Techne model C-85 A, Cambridge, U.K.). The warmed
perfusate was initially passed through a 200 mm and 5 mm ﬁlter
membrane (Millipore, Watford, U.K.), before being introduced into
the aorta at a constant ﬂow of 2–2.5 mlmin1 using a peristaltic
pump (Watson–Marlow Bredel model 505S, Falmouth, Cornwall,
U.K.). The cannulated hearts were perfused for 5 min before further
testing. Viable, healthy hearts then regained a homogenous pink
colouration and spontaneous rhythmic contraction. Hearts that did
not demonstrate these features upon perfusion were instantly
discarded.
2.4. Bipolar electrogram recording
In all experiments analysing the ventricles of the isolated,
perfused murine heart, paired platinum stimulating electrodes
(1 mm interpole spacing) were positioned over the epicardial
surface of the right ventricle. Ventricular activity was examined
by recording from the epicardial surface of the left ventricle using
a silver chloride (2 mm tip diameter) recording electrode (Linton
Instruments, Harvard Apparatus, U.K.), which was manually
positioned. The electrical signals recorded from these hearts
resulted in bipolar electrogram (BEG) recordings. The paired
platinum stimulating electrodes paced the epicardial surface of
the right ventricle and the stimulation used a 2 ms square-wave
stimuli at three times excitation threshold (Grass-Telefactor, U.K.,
Slough, U.K.). These signals were ampliﬁed and high-pass ﬁltered
for recordings of murine heart (30–1 kHz) using a Gould 2400S
ampliﬁer (Gould-Nicolet Technologies, Ilford, Essex, U.K.) and
then digitised using an analogue to digital converter (CED
1401plus MKII, Cambridge Electronic Design, Cambridge, U.K.) at
a sampling frequency of 5 kHz. All digitised data was then
captured and analysed using Spike 2 software (Cambridge
Electronic Design).
2.5. Monophasic action potential recording and regular pacing
In addition to ventricular BEGs, monophasic action potentials
(MAPs) of the ventricles were also recorded using an established
contact-electrode technique (Franz, 1999; Killeen et al., 2007;
Knollmann et al., 2001). The stimulating electrodeswere positioned
on the basal surface of the right ventricular epicardium and used to
deliver electrical stimulation, as described above. Each isolated
perfused heart underwent a period of regular pacing using 2 ms
square-wave stimuli, delivered at three times the excitation
threshold, at a basic cycle length (BCL) of 125 ms, for up to 20 min
to record both epicardial and endocardial MAPs. Epicardial MAPs
were recorded from the basal surface of the left ventricular
epicardium using the silver chloride recording electrode. Endo-
cardial MAPs were also obtained, from the left ventricular endo-
cardium using a custom-made endocardial MAP electrode,
constructed from two Teﬂon-coated (0.25 mm diameter) silver
wires (99.99%) (Advent Research Materials Ltd. Oxford, U.K.), that
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was inserted through a small access window carefully created in
the interventricular septum (Casimiro et al., 2001). The tip of the
electrode was rotated and positioned against the left ventricular
free wall, maintaining stable contact pressure. Signals obtained
from the recording electrode were ampliﬁed and low-pass ﬁltered
between 0.1 Hz and 1.0 kHz using the Gould 2400S ampliﬁer
(Gould-Nicolet Technologies) and digitised using the CED 1401plus
MKII analogue to digital converter (Cambridge Electronic Design)
as described above. Both epicardial and endocardial MAP wave-
forms were analysed using Spike2 software (Cambridge Electronic
Design).
MAPs that were used for analysis, satisﬁed previously estab-
lished waveform characteristics including a stable baseline, a rapid
upstroke phase with consistent amplitude, a smooth contoured
repolarization, a stable duration and 100% repolarization achieved
by a full return to the baseline (Stokoe et al., 2007a). These MAP
waveformswere used to obtain action potential durations (APDs) at
30% (APD30), 50% (APD50), 70% (APD70) and 90% (APD90) repolari-
zation. Transmural gradients of repolarization (DAPD90) were
calculated as endocardial APD90 value minus the epicardial APD90
value (Killeen et al., 2007; Thomas et al., 2007).
2.6. Programmed electrical stimulation
Programmed electrical stimulation (PES) was used to assess
ventricular arrhythmogenesis in each heart preparation and
recorded as BEGs and MAPs (Balasubramaniam et al., 2003;
Saumarez and Grace, 2000). The PES protocol ﬁrst paced the
heart for 25 s at the BCL. This was followed by cycles each con-
sisting of an eight stimuli (S1) drive train at a CL of 125 ms fol-
lowed by a ninth extra-stimulus (S2). The ﬁrst S1–S2 interval
(between the eighth S1 and S2 stimuli) equalled the pacing
interval. Successive cycles progressively reduced the S1–S2
interval by 1 ms until the S2 stimulus could no longer evoke
a ventricular deﬂection, at which point, the whole heart prepa-
ration reached the ventricular effective refractory period (VERP).
VERP was hence deﬁned as the longest S1–S2 interval that could
not elicit a ventricular deﬂection.
From the ventricular BEGs obtained, conduction curves were
constructed, using paced electrogram fractionation analysis (PEFA),
a procedure applied in clinical practice (Head et al., 2005; Saumarez
and Grace, 2000). These curves plotted the response latencies of
each S2 extra-stimulus, deﬁned as the time difference between the
extra-stimulus and the peak and troughs of the resulting BEG,
against the corresponding S1–S2 interval. The electrogram duration
(EGD) is characterised as the time difference between the ﬁrst and
last BEG peak and trough. The EGD ratios from corresponding
conduction curves were calculated by normalizing the EGD of the
BEG obtained from the shortest S1–S2 interval with the EGD of the
longest S1–S2 interval (Stokoe et al., 2007a). The initial conduction
latency was deﬁned as the time difference from the initial S2
stimulus applied at the S1–S2 interval of 125 ms and the initial
deﬂection of the resulting electrogram response.
2.7. Ventricular myocyte isolation
A solution consisting of (in mM): 120 NaCl, 5.4 KCl, 5 MgSO4, 5.5
sodium-pyruvate,10glucose, 20 taurineand10HEPESwasusedas the
basic isolation buffer. This was used to make the following solutions.
Firstly, an NTA buffer consisted of the isolation buffer and 5 mM
nitrilotriacetic acid (NTA). The pH of this buffer was adjusted to 6.95.
Secondly, a digestion buffer, which contained the isolation buffer to
which0.25 mMCaCl2,1 mgml
1 collagenase type2 (Worthington,NJ,
U.S.A.) and 1 mgml1 hyaluronidase (Sigma–Aldrich, Poole, U.K.) wasadded. Thirdly, a stop buffer was created, which contained the isola-
tion buffer and 2 mgml1 bovine serum albumin (Sigma–Aldrich).
Fourthly, the isolation buffer to which 0.6 mM CaCl2 was added, was
createdas thewashbuffer. Finally, a storage buffer, similar to thewash
buffer but with 1.2 mM CaCl2, was made. All the buffers created,
except for the NTA buffer, had their pH adjusted to 7.4.
Hearts of adult mice were rapidly excised and submerged in ice-
cold isolation buffer, prior towhole-heart isolation. The hearts were
then perfused for 2 min with NTA buffer in a retrograde fashion
using a variable speed peristaltic pump at a ﬂow rate of 3.5 mlms1
(Autoclude EV045, Essex, U.K.). Before perfusion, the buffer was
warmed to 37 C with a water jacket and circulator (Techne model
RB-5A,Cambridge,U.K.). Following this, theheartwas thenperfused
in the same fashion with the digestion buffer for 12–15 min. Using
watchmaker’s forceps, ventricular tissue was taken from the whole
heart and placed in the stop buffer. After transferring into a 15 ml
test tube, gentle triturationwas used to isolate singlemyocytes from
the harvested cardiac tissue. After 5 min for the cells to settle, the
supernatant was then gently removed. The isolated cells were then
washed using wash buffer. Following a further 5 min, the isolated
myocytes were resuspended and stored in the storage buffer. After
each step after harvesting the cells, isolatedmyocyteswere checked
under a light microscope to conﬁrm cell integrity. Live myocytes
appeared as smooth and rod-shaped cells.2.8. INa measurements
The biophysical experiments studied the activation, inactivation
and recovery from inactivation in the Naþ channels of WT and
Scn3b/ myocytes. These experiments were carried out at a phys-
iological temperature of 37 C, using the whole-cell conﬁguration,
with an Axopatch 700B ampliﬁer (Molecular Devices, Berkshire,
U.K.). Borosilicate glass pipettes (0.86 mm outer diameter; Harvard
Apparatus, Kent, U.K) with a resistance of 1.5–2.5 MU were used.
These pipettes were ﬁlled with (in mM): 70.26 CsCl, 24.74 Cs-as-
partate, 10 HEPES, 1 Na2ATP, 4 MgATP, 1.37 MgCl2, and 10 Cs-BAPTA,
adjusted to pH 7.2 using CsOH. Cells were loaded into a chamber
which was mounted on the stage of a Nikon TE2000 Eclipse
microscope (Nikon, Kingston, U.K.). These cells were initially
perfused with an extracellular bath solution, which contained (in
mM): 145 NaCl, 5 KCl, 10 glucose, 10 HEPES, 1 MgCl2 and 1 CaCl2,
adjusted to pH 7.4 using NaOH. To achieve optimumvoltage control,
Naþ currents were recorded in a low [Naþ] solution. This solution
contained (in mM): 10 NaCl, 140 CsCl, 10 glucose, 10 HEPES, 1 MgCl2
and 1 CaCl2, adjusted to pH 7.4 using CsOH. The currents obtained
were ﬁltered at a 10 kHz high frequency cut off and digitised at
100 kHz using pClamp 10 software (Molecular Devices). In each
experiment, the series resistance was compensated by at least 70%
and each protocol used a holding potential of 100 mV.
Firstly, the voltage dependence of activation was studied by
applying depolarizing pulses of 20 ms duration. These pulses were
applied over series of voltage steps from 100 mV, in 10 mV
increments, to 70 mV. The resulting currents were normalized
against the cell capacitance (Cm) and plotted against time. The peak
current densities (pA/pF) were calculated by dividing the peak
currents amplitude by Cm. The current–voltage relationship was
obtained by plotting the values of the peak current density against
each corresponding membrane voltage (Vm). The values of peak
Naþ conductance (gNa) values were determined from the equation
gNa ¼ INa=ðVm  ENaÞ;
where INa was the peak current density and the ENa was the [Na
þ]
reversal potential. The ENa was assumed to be 42.6 mV. This was
based on the Nernst equation;
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Naþ
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extracellular=

Naþ

intracellular

;where R is the universal gas constant, T is the absolute temperature
at 310 K, z is the valence of the ionic species at 1, F is Faraday’s
constant, [Naþ]extracellular¼ 10 mM and [Naþ]intracellular¼ 2 mM. The
gNa values calculated from each myocyte were normalized against
the corresponding peak gNa value. When plotted against the test-
pulse voltage, the data assumed a sigmoid function, increasingwith
membrane potential.
Secondly, the voltage dependence of inactivation was
examined using pre-pulses of 500 ms duration. These pre-
pulses were applied over a voltage range from 120 mV to
20 mV in 10 mV increments. Each pre-pulse was followed by
a test pulse to 20 mV at a duration of 10 ms. The peak
currents obtained were normalized against the peak current
recorded at the pre-pulse of 120 mV. The normalized
currents were then plotted against the pre-pulse voltage. The
data assumed a sigmoid function, decreasing with membrane32
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Finally, to determine the time course of recovery from inacti-
vation, a protocol consisting of 18 cycles was employed. Each cycle
consisted of a 1 s pre-pulse to20 mV, used to achieve inactivation
of the Naþ channels, followed by a return to the voltage of100 mV
to allow recovery of the channels. With each cycle, the duration of
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determined the current from the recovered channels. The currents
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Table 1
Metabolic and behavioural tests applied to WT and Scn3b/ mice.
Phenotypic test WT mice Scn3b/ mice Result
Body temperature (C) 37.7 0.1 (n¼ 35) 38.09 0.1 (n¼ 9) P> 0.05
Body weight at 3 months (g)
Males 26.6 0.7 (n¼ 20) 26.9 1.2 (n¼ 5) P> 0.05
Females 21.4 0.5 (n¼ 23) 21.9 0.8 (n¼ 4) P> 0.05
Visual tracking Present Present
Distance travelled (m) 17.69 1.8 (n¼ 10) 14.28 2.3 (n¼ 9) P> 0.05
Plus Maze
% time in closed arm 56.1 4.6 (n¼ 10) 52.0 7.1 (n¼ 10) P> 0.05
% time in open arm 2.2 1.0 (n¼ 10) 2.2 0.9 (n¼ 10) P> 0.05
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Fig. 2. RT-PCR analysis of mRNA expression. The relative abundance of mRNA
(normalized and calculated as % of GAPDH expression) of encoding Naþ channel
subunit transcripts. The histograms show data from the left and right ventricles (LV
and RV respectively) of wild-type (black) and Scn3b/ (white) mice. (A) mRNA tran-
scripts for Scn3b was present in ventricles of WT (left; LV þ/þ, right; RV þ/þ, n¼ 3)
and not detectable in ventricles of Scn3b/mice (left; LV /, right; LV /, n¼ 3). (B)
The expression levels of Scn1b mRNA were signiﬁcantly higher in both the right and
left ventricles of Scn3b/ hearts than shown in WT hearts (P< 0.05). (C) The Scn5a
transcripts were signiﬁcantly higher in the right but not in the left ventricles of
Scn3b/ hearts. mRNA expression levels of Scn3b, Scn1b and Scn5a were consistently
higher in the left than in the right ventricles of both WT and Scn3b/ hearts (n¼ 3
each, P< 0.05) with the exception of Scn3bmRNA expression levels in Scn3b/ hearts.
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where Af and As are the amplitude of the fast and slow inactivating
components, and sf and ss are the time constants of the fast and
slow components, respectively. The y values correspond to the
normalized current values. Data was analysed using Signal 2.16
(Cambridge Electronic Design) and all curve ﬁts were performed
using OriginPro 8 (OriginLab Corporation, MA, USA).
2.9. Data analysis and statistical procedures
For experiments in mRNA expression levels, the single-factor
analysis of variance for independent samples (ANOVA) test was
used to compare the difference between WT and Scn3b/ tissue
samples (Microsoft EXCEL Analysis ToolPak) to show signiﬁcant
changes in expression of the mRNA.
Whole-heart BEG and MAP data were initially imported into
Microsoft EXCEL. The ANOVA test was used to compare WT and
Scn3b/ data sets (Microsoft EXCEL Analysis ToolPak). Calculated
values of P< 0.05 were considered signiﬁcant. Results are shown as
means S.E.M values.
An F-test was used ﬁrstly to conﬁrm the normal distribution of
the data acquired from the Naþ current recordings (Microsoft
EXCEL Analysis ToolPak) made in WT and Scn3b/ myocytes.
Depending on the type of variance, the appropriate form of the
Student t test was applied to analyze the differences between two
groups of data.
3. Results
3.1. Gene targeting of Scn3b and generation of knockout mice
To disrupt the b3 coding region, 191 bp of the 226 bp third exon
of the b3 sequence was replaced by the IRESLacZ/pGKneo cassette
(Fig. 1A). The 50 arm of the plasmid used to generate the mutant
contained a 2.0 kb fragment of the Scn3b locus terminating
downstream of the third coding exon splice acceptor, and a 30 arm
which spanned 4.1 kb of the Scn3b locus commencing just
upstream of the third coding exon splice donor. Successfully tar-
geted ES cells were screened by Southern blot using an external 30
probe (ampliﬁed from mouse genomic DNA using 30prF;
AGATGTCCAGCGATACTGTTGAGGCAG and 30prR; TGTGAGTCT
TATTGGAGGTACAGTGTG). Digestion with AﬂII yielded a 7.7 kb
endogenous band and a 12.6 kb bp targeted band as predicted.
Similar experiments using BclI resulted in a 7.2 kb endogenous
band and the predicted 7.8 kb bp targeted band (Fig. 1B). Homo-
zygous mutant (Scn3b/) offspring were identiﬁed using PCR
screening (Fig. 1C). The primers used (hetF, GTCGTCTGCAGTG
GAATGGGAGCAAAG; hetR, TGAAGAGACTACAGGCCTCAGGCTTAC;
and Asc306, AATGGCCGCTTTTCTGGATTCATCGAC) resulted in the
generation of a 204 bp band from the wild-type (WT) (þ/þ) allele,
and a 334 bp band from the Scn3b/ (/) allele. Both bands werepresent in the heterozygote (þ/) allele. A water control was used
to conﬁrm the speciﬁcity of the PCR primers.
To assess the phenotype of the Scn3b/ mice, both metabolic
and behavioural tests were used. The body weight and temperature
of these mice were similar to those obtained from WT mice
(Table 1). Additionally, vision, locomotor activity and anxiety tests
showed similar results in both WT and Scn3b/ mice (Table 1).3.2. mRNA expression levels of Naþ channel subunits in
murine ventricles
The mRNA expression studies demonstrated that Scn3b mRNA
was not present and an increase in Scn1bmRNA in both the left and
right ventricles of Scn3b/ hearts. An increase in the Scn5a mRNA
was observed only in the right ventricles of Scn3b/ hearts. In all
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higher. Reverse-transcriptase PCR (RT-PCR) was used to investigate
mRNA expression levels of sodium (Naþ) channel b-subunits Scn3b,
Scn1b, and the cardiac Naþ channel a-subunit, Scn5a, in tissue
obtained from the right and left ventricles of mousewild-type (WT)
(RVþ/þ and LVþ/þ; n¼ 3) and Scn3b/ hearts (RV/ and LV/;
n¼ 3). The number of the copies of mRNA was calculated from its
respective threshold cycle (CT) using a standard curve. Each value
was normalized to the corresponding expression of the house-
keeping gene, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH).
This made comparison between samples possible by correcting
for any variation between the quantity of mRNA isolated from the
WT and transgenic mouse hearts. Transcript expression was
expressed as relative abundances of mRNA expression, calculated
as a % of the GAPDH expression (i.e. 2DCT 100). Firstly, the mRNA
encoding the b3 subunits, Scn3b, was expressed at statistically
similar levels in both the left and right ventricles of WT hearts
(Fig. 2A, black column, n¼ 3, P< 0.05). In contrast, both the
ventricles of Scn3b/ hearts (n¼ 3), as expected, did not show any
detectable expression of Scn3b mRNA.
Secondly, both the left and right ventricles of the Scn3b/
hearts (Fig. 2B,white column) showed an increase in the expression
levels of Scn1b mRNA, relative to corresponding values in WT
hearts (P< 0.05). Finally, Fig. 2C conﬁrms the expression of the
mRNA encoding for the a-subunit of the Naþ channel, Scn5a, in both
ventricles of WT (black columns) and Scn3b/ (white columns)
hearts. The left ventricles of WT and Scn3b/ hearts demonstrated
similar levels of Scn5a mRNA expression (P> 0.05). However, the
right ventricles of the Scn3b/ hearts demonstrated a small but
signiﬁcant increase in the expression of Scn5a mRNA, than that
shown in WT hearts (P< 0.05). Thus, mRNA expression levels ofBEG (V)
1 sec
BEG (V)
1 sec
A
B
Fig. 3. BEG recordings of programmed electrical stimulation (PES) from WT and Scn3b/
refractory period (VERP) was obtained from all WT hearts studied (n¼ 6). (B) BEG recor
ventricular tachycardia (VT) in 5 out of 7 Scn3b/ heart preparations.Scn1b and Scn5a were always higher in the left than in the right
ventricles of WT and Scn3b/ hearts (n¼ 3 each, P< 0.05).
3.3. Analysis of BEG recordings during PES
The mRNA expression changes were correlated with a ventric-
ular arrhythmogenic phenotype in Scn3b/ hearts. This was
demonstrated in electrophysiological experiments that assessed
ventricular arrhythmogenicity in isolated, Langendorff-perfused
WT and Scn3b/ murine hearts. This was achieved by obtaining
bipolar electrogram (BEG) (ﬁrst series; 6 WT hearts and 7 Scn3b/
hearts) and monophasic action potential (MAP) (second series; 14
WT hearts and 17 Scn3b/ hearts, third series; 4 WT hearts and 4
Scn3b/ hearts) recordings from the left ventricles. BEGs andMAPs
were obtained once the preparations had regained a steady state
after 10 min following mounting. BEG recordings were obtained
during programmed electrical stimulation (PES). This procedure
has been used in clinical situations to assess arrhythmogenicity and
applied to murine hearts as described on previous occasions
(Balasubramaniam et al., 2003; Saumarez and Grace, 2000). Hearts
were initially paced at a basic cycle length (BCL) of 125 ms for 25 s.
Subsequent cycles used a drive train each consisting of eight stimuli
(S1) at the same BCL, followed by a premature extra-stimulus (S2).
The initial S2 stimulus was imposed at an S1–S2 interval of 125 ms.
With each cycle, this interval was reduced by 1 ms, until either the
ventricular effective refractory period (VERP) was reached, at
which point the premature S2 did not trigger a response or resulted
in ventricular tachycardia (VT).
Fig. 3 shows examples of BEG traces obtained during PES. Each
trace demonstrates results from the ﬁnal cycles that corresponded
to the shortest S1–S2 intervals. The single vertical marks below each
recording indicate the successive S1 stimuli and the double verticalVT
VERP
hearts. (A) PES of an isolated, WT Langendorff-perfused heart. Ventricular effective
ding showing PES of an isolated, Scn3b/ Langendorff-perfused heart. PES induced
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stimulus artefacts that occurred at regular CL, followed by their
resulting electrogram. In the case of WT hearts (Fig. 3A), shortening
of the S1–S2 interval led to an S2 extra-stimulus that did not elicit an
electrogram. This S1–S2 interval corresponded to the VERP. In
contrast, under such circumstances, a signiﬁcant proportion of
Scn3b/ hearts showed ventricular arrhythmias (Fig. 3B).
Conduction curves were then derived from the BEG recordings
obtained during PES, using paced electrogram fractionation anal-
ysis (PEFA), a procedure that has been used to assess clinical risk of
ventricular arrhythmogenicity on earlier occasions (Saumarez and
Grace, 2000). It has also been previously applied to assess
arrhythmogenicity in Kcne1/ (Balasubramaniam et al., 2003),
Scn5aþ/DKPQ (Head et al., 2005; Stokoe et al., 2007b) and Scn5aþ/
(Stokoe et al., 2007a) murine hearts. Fig. 4A–D illustrates
S2-induced BEG waveforms at a faster time base than shown in
Fig. 3 in order to demonstrate differences in electrogram duration
(EGD). This was deﬁned as the time interval between the ﬁrst and
last deﬂection of each electrogram waveform. These waveforms
were obtained during PES of WT (Fig. 4A, B) and Scn3b/ (Fig. 4C,
D) hearts. The waveforms in Fig. 4A, C were induced by the S2
stimuli at the longest S1–S2 intervals that were identical to the BCL,
employed at the beginning of the procedure. The duration of these
waveforms were deﬁned as the initial EGD. The waveforms in
Fig. 4B, D were induced by the S2 stimuli at the shortest S1–S2E
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Fig. 4. Electrogram waveforms and conduction curves from programmed electrical
stimulation (PES) and bipolar electrogram (BEG) recordings. The electrograms recor-
ded at the longest S1–S2 interval (basic cycle length of 125 ms) in WT hearts (A) were
signiﬁcantly shorter in duration than in Scn3b/ hearts (C). Similarly, electrograms
obtained prior to the heart becoming refractory or arrhythmic were consistently
shorter in duration in WT hearts (B) than those recorded in Scn3b/ hearts (D). (E)
Conduction curves were created by the application of paced electrogram fractionation
analysis (PEFA) to PES data obtained from WT (white circles) and Scn3b/ hearts
(black circles). The vertical axis represents latency (ms) and the horizontal axis, the
S1–S2 interval (ms). The representative conduction curve demonstrates a greater
increase in electrogram duration at the shortest S1–S2 interval and shorter VERP in
Scn3b/ hearts, than recorded in WT hearts.intervals that could elicit an electrogram response, at the end of the
procedure. The duration of these waveforms were deﬁned as the
ﬁnal EGD. The EGD ratio was calculated as the ﬁnal EGD divided by
the initial EGD. The initial conduction latency was calculated as the
time difference from the initial S2 extra-stimulus applied at the
S1–S2 interval of 125 ms and the resulting BEG.
Fig. 4E shows examples of the conduction curves in WT and
Scn3b/ hearts. Each of the curves plots the latencies of each peak
and trough of each deﬂection contained in the electrogram from
the S2 stimulus against the corresponding S1–S2 interval. Such
curves demonstrate increases in the degree of spread of each
electrogram and conduction latency as S1–S2 interval shortens.
However, these changes are more marked in Scn3b/ hearts.
A greater increase in the EGD was observed in Scn3b/ hearts with
shortening of the S1–S2 interval, (D, ﬁlled circles) compared to the
EGD shown inWT hearts (B, clear circles). Fig. 4E also demonstrates
the signiﬁcantly shorter VERP observed in Scn3b/ hearts than in
WT hearts. Tables 2 and 3 summarise the VERP, initial and ﬁnal EGD
values, EGD ratios and conduction latencies obtained from the PEFA
analysis of WT and Scn3b/ hearts. It was possible to determine
a VERP in only 2 out 7 Scn3b/ hearts, with the remaining 5 hearts
demonstrating PES-induced VT (Table 3). Nevertheless, the mean
S1–S2 interval at which VERP and arrhythmogenicity occurred in
Scn3b/ hearts was 24.71.6 ms (n¼ 7 hearts), which was
signiﬁcantly shorter than the VERP of the WT hearts studied
(31.21.5 ms, n¼ 6, P< 0.05). Scn3b/ hearts showed signiﬁ-
cantly larger initial and ﬁnal EGD values (17.13.8 ms and
34.6 6.6 ms respectively, n¼ 7; Table 3) compared to those of WT
hearts (2.3 0.4 ms and 2.8 0.4 ms, n¼ 6, P< 0.05; Table 2).
Furthermore, Scn3b/ hearts demonstrated a larger mean EGD
ratio than that shown in WT hearts (2.10.2 ms, n¼ 7 vs.
1.3 0.1ms n¼ 6, P< 0.05). WT and Scn3b/ hearts both showed
similar conduction latencies (8.0 0.4ms vs. 8.3 0.2ms P> 0.05;
Tables 2 and 3).
3.4. Analysis of MAP recordings during PES
Analysis of MAP recordings permitted a closer differentiation of
hearts with arrhythmogenic and non-arrhythmogenic phenotypes
as well as of monomorphic and polymorphic VT. MAP waveforms
were compared during PES in a second series of isolated, perfused
WTand Scn3b/ hearts. Each heart was subjected to an application
of a single procedure of PES. This made it possible to determine
when VT occurred, whether it was monomorphic or polymorphic.
Fig. 5 illustrates MAP recordings obtained from WT (A) and
Scn3b/ (B, C) hearts during the ﬁnal cycles of a PES procedure that
corresponded to the shortest S1–S2 intervals. In each panel, the
single vertical mark below each recording indicates the S1 stimuli
and the double vertical mark the S2 extra-stimulus. The traces also
show the corresponding stimulus artefacts that occurred at
a regular CL, closely followed by their elicited MAP. MAPs inTable 2
Ventricular effective refractory period, EGDs and latencies measured in BEG
recordings of (‘‘’’¼ absent; ‘‘þ’’¼ present).
WT
Heart Arrhythmogenic? VERP
(ms)
Initial
EGD (ms)
Final
EGD (ms)
EGD
ratio
Latency
(ms)
1  27 1.87 3 1.6 7.9
2  35 2.2 2.2 1.0 9.6
3  28 4.06 4.6 1.1 8.3
4  36 1.4 1.8 1.3 8.2
5  32 1.3 1.9 1.5 6.7
6  29 2.84 3.4 1.2 7.4
Mean S.E.M. 31.2 1.5 2.3 0.4 2.8 0.4 1.3 0.1 8.0 0.4
Table 3
Ventricular effective refractory period, S1–S2 interval of PES-induced VT, EGDs and
latencies measured in BEG recordings of Scn3b/ hearts.
Scn3b/
Heart Arrhythmogenic? VERP
(ms)
Initial
EGD
(ms)
Final
EGD
(ms)
EGD
ratio
Latency
(ms)
1 þ <21 30.5 62.2 2.0 8.3
2 þ <23 16.0 36.2 2.3 8.2
3 þ <33 31.4 55.0 1.8 8.6
4  24 12.8 26.4 2.1 7.5
5  26 5.6 17.3 3.1 9.6
6 þ <26 11.9 21.8 1.8 8.0
7 þ >20 11.6 23.1 2.0 8.3
Mean
 S.E.M.
24.7 1.6a 17.1 3.8a 34.6
 6.6a
2.1
 0.2a
8.3
 0.2b
a P< 0.05 vs. WT (see Table 2).
b P> 0.05 vs. WT (see Table 2) (‘‘’’¼ absent; ‘‘þ’’¼ present).
B
0.5 sec
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C
0.5 sec
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A
MAP (V)
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S2-induced AP
Fig. 5. Monophasic action potential (MAP) recordings of PES from WT and Scn3b/ hearts
action potential (AP) and VERP was observed in all WT hearts studied (n¼ 14). (B) PES-induc
demonstrating a monomorphic VT. (C) An episode of PES-induced VT in a Scn3b/ heart p
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Scn3b/ hearts, with each AP demonstrating a stable baseline,
rapid upstroke and smooth repolarisation phase (Fabritz et al.,
2003; Guo et al., 1999; Killeen et al., 2007). Neither demonstrated
spontaneous events such as early or delayed afterdepolarizations
that were reported in hypokalaemic and Scn5aþ/DKPQ murine hearts
(Killeen et al., 2007; Thomas et al., 2008).
Fig. 5A shows a typical MAP recording obtained during the ﬁnal
cycles of the PES procedure in a WT heart. The ﬁrst S2 extra-stim-
ulus that is displayed, gave rise to an action potential. However, the
heart was refractory in response to the second S2 extra-stimulus,
thereby permitting the determination of the VERP. In contrast,
Scn3b/ hearts showed episodes of either monomorphic (Fig. 5B)
or polymorphic VT (Fig. 5C) following an S2 extra-stimulus.
Monomorphic VT showed successive ventricular deﬂections that
were of similar waveform and amplitude. Polymorphic VT
demonstrated varying intervals between each successive deﬂectionMonomorphic VT
Polymorphic VT
VERP
. PES of isolated Langendorff-perfused WT (A) and Scn3b/ (B, C) hearts. S2-induced
ed episodes of VT occurred in 10 out of 17 Scn3b/ hearts, with ﬁve such preparations
reparation began as a monomorphic VT and deteriorated into polymorphic VT.
P. Hakim et al. / Progress in Biophysics and Molecular Biology 98 (2008) 251–266260with irregular amplitudes and waveforms. Table 4 summarises the
properties of the MAP waveforms during PES in WT (n¼ 14) and
Scn3b/ hearts (n¼ 17). It lists the VERP shown in non-arrhyth-
mogenic hearts. Where the heart was arrhythmogenic, it lists the
S1–S2 interval value, which would be less than the VERP. The WT
hearts had a mean VERP of 39.31.6 ms (n¼ 14). PES did not
induce VT in any of the WT hearts. In contrast to WT hearts, only 7
out of 17 Scn3b/ hearts were non-arrhythmogenic. These hearts
had a mean VERP of 43.3 4.4 ms (n¼ 7). This was not signiﬁcantly
different from the corresponding mean VERP, recorded in WT
hearts (n¼ 14, P> 0.05). The remaining Scn3b/ hearts were
arrhythmogenic in response to a mean S1–S2 interval of
<29.3 2.4 ms (n¼ 10). This was signiﬁcantly shorter than the
VERP of the WT (n¼ 14) and non-arrhythmogenic Scn3b/ hearts
(n¼ 7; P< 0.05). The mean duration of the VT was 98.85 39.8 s
(Fig. 5B, C). In 5 out of the 10 arrhythmogenic hearts, the hearts
showed monomorphic VT (Fig. 5B). The mean duration of episodes
of monomorphic VT was 100.6 46.4 s (Table 5). In 4 hearts out of
10 arrhythmogenic hearts, the hearts demonstrated polymorphic
VT. The mean duration of the polymorphic VT was 27.313.8 s.
Finally, PES-induced VT in the remaining heart began as a mono-
morphic VT and deteriorated into polymorphic VT (Fig. 5C). This
persisted until spontaneous termination of the episode.
3.5. Endocardial and epicardial MAP recordings in WT and
Scn3b/ hearts
Comparison of endocardial and epicardial recordings suggested
that Scn3b/ hearts showed a shorter endocardial and epicardial
APD90 which nevertheless demonstrated a normal transmural
gradient of repolarization, DAPD90. Previous studies have demon-
strated that arrhythmogenic properties were associated with
abnormal differences in epicardial and endocardial APDs (Killeen
et al., 2007; Stokoe et al., 2007b). The present investigation made
similar experiments, which recorded MAPs at the BCL from the left
ventricular epicardium and endocardium of a third series of hearts.
Measurements were obtained from ﬁve separate 20 s periods
during regular pacing. For each period taken, the recording elec-
trode was repositioned to obtain independent readings fromTable 4
Ventricular effective refractory periods and S1–S2 (þ) intervals of PES-induced VT in MA
Heart WT Heart Scn3b/
Arrhythmogenic? VERP (ms) Arrhythmo
1  46 1 
2  42 2 
3  35 3 
4  38 4 
5  32 5 
6  36 6 
7  46 7 
8  49 8 þ
9  36 9 þ
10  30 10 þ
11  35 11 þ
12  40 12 þ
13  47 13 þ
14  38 14 þ
15 þ
16 þ
17 þ
Mean S.E.M 39.3 1.6 Arrhythmo
Non-arrhy
Poly: Polymorphic VT.
Mono: Monomorphic VT.
a P< 0.05 vs. WT.
b P> 0.05 vs. WT.different regions of the ventricle. This was to ensure the values
obtained were comparable. Action potential duration (APD) at 30%
(APD30), 50% (APD50), 70% (APD70) and 90% (APD90) repolarization
values were obtained from the MAPs.
Tables 6 and 7 summarise the APD values obtained from the
epicardium and endocardium. Endocardial APD values in Scn3b/
hearts were signiﬁcantly shorter than their corresponding WT
endocardial values. Thus, the endocardial APD30, APD50, APD70 and
APD90 recorded in WT hearts (n¼ 4) were 10.51.4, 18.8 2.1,
31.2 2.9 and 53.6 2.7ms respectively (Fig. 6A). The same
measurements made in Scn3b/ hearts demonstrated APD values
of 6.2 0.1 ms,12.31.2 ms, 20.21.6 ms and 41.0 3.8 ms (n¼ 4,
P< 0.05). Furthermore, Scn3b/ epicardial APD70 and APD90 values
were also signiﬁcantly shorter than their respective WT APD70 and
APD90 values. Thus, the epicardial APD70 and APD90 values obtained
from WT hearts were 17.71.6ms and 38.72.8ms respectively
(Fig. 6B). Equivalent measurements obtained from Scn3b/ hearts
were 10.2 0.8 ms and 27.5 2.3 ms respectively (n¼ 4, P< 0.05).
Epicardial APD30 and APD50 values were both similar in WT and
Scn3b/ hearts (P> 0.05). The transmural gradient of repolariza-
tion (DAPD90) was quantiﬁed as the difference between the values
of the endocardial APD90 and epicardial APD90 (Killeen et al., 2007).
The Scn3b/ and WT hearts showed similar positive DAPD90
(14.0 3.4 ms vs. 15.4 4.4 ms, P> 0.05) (Fig. 6C). This is despite
a decrease in epicardial and endocardial values observed in
Scn3b/ hearts.
3.6. Naþ current recordings in isolated ventricular myocytes
The electrophysiological changes in the Scn3b/ whole heart
was correlated with a reduction in the peak Naþ current and a shift
in the inactivation curve in the negative direction. The activation
properties and recovery from inactivation remained similar in WT
and Scn3b/myocytes. The effects of the expression of b3 subunits
on Naþ currents were assessed using the whole-cell patch-clamp
technique on cardiac myocytes isolated from WT and Scn3b/
hearts. In all experiments, the series resistance was compensated
by at least 70% and each protocol used a holding voltage of
100 mV.P recordings of WT and Scn3b/ hearts.
genic? VERP (ms) Duration of VT (sec) Type of VT
40 – –
<41 20.715 Poly
50 – –
31 – –
<36 21.54 Mono
<31 376.176 Mono/ Poly
30 – –
45 – –
<22 150.386 Mono
<31 1.11 Poly
64 – –
<31 21.24 Poly
<22 72.5 Mono
<37 3.1 Mono
43 – –
<24 255.62 Mono
<18 66.16 Poly
genic (þ) <29.3 2.4a 98.9 39.8 (n¼ 10) –
thmogenic () 43.3 4.4b
Table 7
Epicardial monophasic APDs of WT and Scn3b/ hearts.
Parameters (ms) Epicardial
Wild-type (n¼ 4) Scn3b/ (n¼ 4)
APD30 4.1 0.8b 2.8 0.4b
APD50 8.5 0.6b 5.8 1.0b
APD70 17.7 1.6b 10.2 0.8a,b
APD90 38.7 2.8b 27.5 2.3a,b
a P< 0.05 vs. WT.
b P< 0.05 vs. Endocardial value (in Table 6).
Table 5
Number of arrhythmogenic Scn3b/ hearts, in MAP recordings, showing PES-in-
duced monomorphic ventricular tachycardia (mVT), polymorphic ventricular
tachycardia (pVT) or both (mVTþ pVT).
Type of VT No. of hearts Mean duration S.E.M. (sec)
mVT 5 100.6 46.4
pVT 4 27.3 13.8
mVTþ pVT 1 376.2
Total VT 10 98.9 39.8
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vation were assessed using a pulse protocol which applied depo-
larizing pulses of 20 ms duration, from a holding potential of
100mV, to test potentials between 90 and 70 mV in 10 mV
increments. Fig. 7A compares families of representative current
traces obtained from WT (left panel) and Scn3b/ (right panel)
myocytes in response to voltage steps, between the test potentials
of 100 to 30 mV. In all the WT and Scn3b/ myocytes examined,
the greatest magnitude of peak Naþ current density was observed
at voltage steps to either 30 or 40 mV. However, the maximum
value of the peak Naþ current density was signiﬁcantly smaller in
the Scn3b/ myocytes, compared to that shown in WT myocytes
(Fig. 7A). Thus, Fig. 7B demonstrates that the maximumvalue of the
peak current density at30 mVwas signiﬁcantly reduced by 30% in
Scn3b/ myocytes when compared to that shown in WT myocytes
(90.4 4.3 pA/pF, n¼ 7 vs. 63.3 4.8 pA/pF, n¼ 7 each, P< 0.001;
Table 8). Furthermore, Fig. 7C plots the peak Naþ current densities
obtained from WT and Scn3b/ myocytes against the cor-
responding test potentials. The peak Naþ current densities in
Scn3b/myocytes (Fig. 7C, white triangles) at30 (P< 0.001),20
(P< 0.001), 10 (P< 0.001) and 0 mV (P< 0.05) were signiﬁcantly
smaller than the corresponding densities recorded inWTmyocytes
(black triangles, n¼ 7 each).
Secondly, to examine changes in the biophysics of the Naþ
channel activation and inactivation properties were assessed inWT
and Scn3b/ myocytes. The activation function of Naþ channels
(Fig. 8A, squares) in WT (black) and Scn3b/ (white) myocytes was
obtained by plotting the peak Naþ conductance (gNa) (peak gNa)
values against Vm. Peak gNa values were calculated by the following
formula;
gNa ¼ INa=ðVm  ENaÞ;
where INa was the peak current density, Vmwas membrane voltage
and the ENa was the reversal potential of Na
þ ions. This was
calculated from the intracellular and extracellular Naþ concentra-
tion as an assumed value of 42.6 mV. The peak gNa values obtained
were normalized to the corresponding maximum peak gNa values.
Thirdly, the voltage dependence of inactivation was assessed
using pre-pulses of 500 ms duration. These pre-pulses were
applied over a voltage range from 120 to 20 mV in 10 mV
increments. A test pulse to 20 mV of duration of 10 ms immedi-
ately followed this. The resulting currents were normalized against
the Naþ current recorded at the pre-pulse at 120 mV. The inac-
tivation function (Fig. 8A, circles) in WT (black) and Scn3b/Table 6
Endocardial monophasic APDs of WT and Scn3b/ hearts.
Parameters (ms) Endocardial
Wild-type (n¼ 4) Scn3b/ (n¼ 4)
APD30 10.5 1.4 6.2 0.1a
APD50 18.8 2.1 12.3 1.3a
APD70 31.2 2.9 22.0 1.4a
APD90 53.6 2.7 41.0 3.8a
a P< 0.05 vs. WT.(white) myocytes was obtained by plotting the normalized currents
against Vm. The continuous lines display the Boltzmann functions
ﬁtted to the activation and inactivation data. The data was used to
obtain the half-maximal voltages (V1/2) and slope factor (k) values
of both activation and inactivation in WT and Scn3b/ myocytes
(Table 8). The activation function of the Naþ channel in WT and
Scn3b/ myocytes remained similar, despite a smaller Naþ current
recorded in Scn3b/ myocytes. Thus, the V1/2 and k values of WT
(41.0 0.2 mV and 2.4 0.3 mV) were similar to those in
Scn3b/ hearts (43.6 0.4 mV and 2.10.2 mV, n¼ 7 each,
P> 0.05). However, the inactivation curve of the Naþ channels in
Scn3b/ myocytes was shifted in the negative direction relative to0
10
WT Scn3b-/-
D
Fig. 6. Action potential durations (APDs) in WT and Scn3b/ hearts. Comparison of
endocardial (endo) (A) and epicardial (epi) (B) APD values, measured at 30%, 50%, 70%
and 90% repolarization for WT (n¼ 4) and Scn3b/ hearts (n¼ 4) (black and white
columns respectively). All endocardial APD recordings, epicardial APD70 and APD90
were signiﬁcantly shorter. (C) Endocardial and epicardial APD measured at 90%
repolarization (APD90) values (black and white columns respectively), alongside
DAPD90 values for WT and Scn3b
/ hearts, which showed no signiﬁcant difference
(striped column; P> 0.05). *P< 0.05.
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Fig. 7. Peak Naþ current densities in WT and Scn3b/ myocytes. Representative Naþ current traces recorded fromWT (A, left panel) and Scn3b/ (A, right panel) myocytes. (B) The
peak Naþ current densities were signiﬁcantly smaller in Scn3b/ myocytes (white column, n¼ 7) compared to those shown in WT myocytes (black column, n¼ 7). (C) The current–
voltage relationship demonstrated a smaller Naþ current in Scn3b/ myocytes (white triangles, n¼ 7) between the voltage steps of 30 and 0 mV compared to those shown in WT
myocytes (black triangles, n¼ 7). *P< 0.05, ***P< 0.001. All recordings were obtained at 37 C.
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voltage dependence of inactivation of WT and Scn3b/ myocytes
was 59.5 0.4 mV and 67.0 0.4 mV respectively (n¼ 7 each,
P< 0.01).
However, the slope factors of the inactivation curves were
similar in WT and Scn3b/ myocytes (WT; 5.7 0.3 mV vs.
Scn3b/; 6.4 0.4 mV, n¼ 7 each, P> 0.05). At the holding
potential of100 mV, the normalized inactivation current was 0.95
in both WT and Scn3b/ myocytes (Fig. 8A). However, at a depo-
larized potential of 80 mV, the normalized values were 0.93 and
0.84 in WT and Scn3b/ myocytes respectively. This suggests that
at 80 mV, an additional 10% of the channels in Scn3b/myocytes
were already inactivated, compared to those in WT myocytes.
Furthermore, the percentage of inactivated channels in Scn3b/
myocytes, compared to WT myocytes, increases to 37% at a poten-
tial of 70 mV. This was calculated from the normalized current
values of 0.83 and 0.61 in WT and Scn3b/ myocytes respectively.Table 8
INa properties in myocytes.
Wild-type (n¼ 7) Scn3b/(n¼ 7)
Peak INa density (pA/pF) 90.4 4.3 63.3 4.8***
Voltage dependence of activation V1/2 (mV) 41.0 0.2 43.6 0.4
k (mV) 2.3 0.3 2.1 0.2
Voltage dependence of inactivation V1/2 (mV) 59.5 0.4 67.0 0.4**
k (mV) 5.7 0.3 6.4 0.4
Recovery from inactivation s-Fast (ms) 2.3 0.5 2.1 0.2
Af 0.83 0.07 0.97 0.04
s-Slow (ms) 27.1 7.5 39.5 5.3
As 0.3 0.05 0.27 0.02
** P< 0.01, *** P< 0.001.Finally, the time course of recovery from inactivation was
examined using a 1 s pre-pulse to 20 mV. This was followed by
a return to the holding voltage of 100 mV to allow recovery, at
varying durations between 1 and 250 ms. A test pulse at a duration
of 50 ms to20 mV determined the current observed in fractions of
recovered channels. The currents recordedwere normalized against
the current obtained from each of the 1 s pre-pulses applied. To
determine the relative proportion of channels that were in the fast
(s-fast) and slow (s-slow) phase, a 2-exponential functionwas ﬁtted
to the data (Fig. 8B, Table 8). No signiﬁcant differences were
observed in the time constants and fractions of the s-fast (WT;
2.3 0.5 ms and 0.83 0.07, n¼ 7 vs. Scn3b/; 2.10.2 ms and
0.97 0.04, n¼ 7, P> 0.05) and s-slow (WT; 27.17.5 ms and
0.3 0.05, n¼ 7 vs. Scn3b/; 39.5 5.3 ms and 0.27 0.02, n¼ 7,
P> 0.05) values obtained (Fig. 8B).
4. Discussion
Sodium (Naþ) channel function is critical for normal initiation,
conduction and propagation of cardiac electrical activity (Grant,
2001). Thus, mutations in the SCN5A gene, which encodes for the
pore-forming a-subunit of the cardiac Naþ channel Nav1.5, result in
clinical arrhythmic conditions that include the Brugada syndrome
(BrS) (Brugada and Brugada, 1992; Chen et al., 1998) and long QT
syndrome 3 (LQT3) (Wang et al., 1995). These conditions have been
reproduced in genetically modiﬁed, Scn5aþ/ and Scn5aþ/DKPQ,
murine models, respectively (Head et al., 2005; Papadatos et al.,
2002). Murine models have also been useful in studying the
consequences of alterations in the potassium (Kþ) channel, such as
mutations in the KCNE1 subunit resulting in LQT5 (Balasu-
bramaniam et al., 2003; Vetter et al., 1996) and of acute conditions
such as hypokalaemia (Killeen et al., 2007).
P. Hakim et al. / Progress in Biophysics and Molecular Biology 98 (2008) 251–266 263There have been fewer studies of b- than a-subunits of ion
channels in murine systems, particularly those associated with the
Naþ channel. One or more of such b-subunits associate with an
a-subunit to form the complete channel (Catterall, 2000). So far, six
types of Naþ channel b-subunits have been identiﬁed and cloned.
Of these, the b1 (Isom et al., 1992), b2 (Isom et al., 1995a), b3
(Morgan et al., 2000) and b4 subunits (Yu et al., 2003) are encoded
by SCN1B, SCN2B, SCN3B and SCN4B respectively. The remaining b1A
(Kazen-Gillespie et al., 2000) and b1B (Qin et al., 2003) subunits are
generated by splice variants of SCN1B. mRNA transcripts encoding
for these b1, b2, b3 and b4 subunits are expressed in a wide range of
human tissues that include brain, skeletal (Candenas et al., 2006)
and cardiac muscle (Isom et al., 1995b; Makita et al., 1994; Morgan
et al., 2000; Qin et al., 2003; Yu et al., 2003). The expression of these
subunits is thought to be important in normal surface expression
(Isom et al., 1995b) and determining the biophysical characteristics
of the Naþ channel (Chen et al., 2002; Meadows et al., 2002;-120 -100 -80 -60
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Fig. 8. Steady-state activation, inactivation and recovery from inactivation properties in WT a
and inactivation (circle symbols) in WT (black symbols) and Scn3b/ (white symbols) myoc
were signiﬁcantly smaller in Scn3b/ myocytes (n¼ 7) between the voltage steps of 70 an
to study the voltage dependence of activation and inactivation are shown in the inset. (B)
myocytes. The solid lines represent double-exponential ﬁts. The derived biophysical prope
obtained at 37 C.Morgan et al., 2000; Patton et al., 1994). It has also been suggested
that cleaved forms of the b-subunitsmay act as transcription factors
for mRNA transcripts encoding for Naþ channel subunits. Thus, the
cleaved intracellular domain of the b2 subunit has been shown to
increase the expression of Nav1.1 a-subunits (Kim et al., 2007).
Furthermore, the ventricles of Scn1b/ hearts have greater
expression levels of Scn5a mRNA than do WT hearts (Lopez-San-
tiago et al., 2007). Modiﬁcations in b-subunits thus have potential
effects on cardiac electrophysiology.
We report, for the ﬁrst time, that deﬁciencies in the Scn3b gene
in a murine system lead to altered biochemical and biophysical
properties of the Naþ channel, resulting in abnormal ventricular
electrophysiology. Scn3b/ mice were ﬁrst created using homol-
ogous recombination in embryonic stem (ES) cells. Such mice
showed no signiﬁcant changes in behavioural and metabolic tests
compared to those assessed in WT mice. These ﬁndings are in
contrast to those shown in Scn1b/ mice, which demonstrate-40 -20
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ytes. The solid lines represent the Boltzmann ﬁts. The normalized inactivation currents
d 40 mV compared to those shown in WT myocytes (n¼ 7). The pulse protocols used
Recovery from inactivation in WT (black diamonds) and Scn3b/ (white diamonds)
rties are summarised in Table 8. *P< 0.05, **P< 0.01, ***P< 0.001. All recordings were
Table 9
Alterations in electrophysiological features in the hearts of Scn3b/mice relative toWT hearts, compared with corresponding changes in arrhythmogenic murine models and
clinical Brugada Syndrome.
Features Scn3b/ Arrhythmogenic
Scn5aþ/
Arrhythmogenic
Scn5aþ/DKPQ
Kcne1/ Hypokalaemic Clinical BrS References
(A) Whole heart properties
PES VT þ þ þ þ þ þ 1–5
Increased EGD þ þ þ þ Not assessed þ 2, 3, 5, 6
Initial conduction
latency
No change No change Increased3 No change Not assessed Not assessed 2, 3, 5, 7
No change7
VERP Shorter No change2 No change No change Shorter Short 2, 3, 5, 7–10, 23
Longer9 Longer3
DAPD90 No change No Change Negative Negative Negative Varied 2, 4, 7, 11–13
(B) Single cell properties
Peak Naþ current density Reduced Reduced Greater N/A N/A Reduced 3, 9, 14
Naþ channel activation No change No change No Change N/A N/A Positive shift 15–19
Negative
shift
20
No Change 21
Naþ channel inactivation Negative
shift
No change No change N/A N/A Positive shift 17, 21, 22
Negative
shift
15, 16, 18, 20
No Change 18, 20
Naþ channel recovery
from inactivation
No change Not assessed No Change N/A N/A Faster 17–20, 22
Slower 21
No change 15, 16, 20
Key: 1¼Morita et al., 2003, 2¼ Stokoe et al., 2007a, 3¼Head et al., 2005, 4¼ Killeen et al., 2007, 5¼ Balasubramaniam et al., 2003, 6¼ Saumarez et al., 2003, 7¼ Stokoe et al.,
2007b, 8¼Watanabe et al., 2005, 9¼ Papadatos et al., 2002, 10¼ Sabir et al., 2007, 11¼Antzelevitch, 2001, 12¼ Kurita et al., 2002, 13¼ Thomas et al., 2007, 14¼ Chen et al.,
1998,15¼ Baroudi and Chahine, 2000,16¼Wan et al., 2001,17¼ Zhang et al., 2007,18¼Akai et al., 2000,19¼Dumaine et al., 1999, 20¼ Rook et al.,1999, 21¼ Chen et al., 1998,
22¼Wang et al., 2000, 23¼Wilde et al., 2002. (‘‘’’¼ absent; ‘‘þ’’¼ present).
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et al., 2004). Reverse-transcriptase polymerase chain reaction
(RT-PCR) analysis not only conﬁrmed the presence or absence of
Scn3b mRNA in WT and Scn3b/ hearts respectively, but also that
the Scn3b mRNA or protein may exert a regulatory role on the
expression of Scn1b and Scn5amRNA in murine ventricles. Firstly, it
demonstrated that Scn3b mRNA was expressed in wild-type (WT)
with similar expression in both the left and right ventricles. This
was in agreement with previous studies that had demonstrated
that b3 subunits were expressed in the ventricular myocytes
obtained from WT and Scn1b/ mouse hearts, speciﬁcally in the
transverse tubules (Lopez-Santiago et al., 2007; Maier et al., 2004).
As expected, Scn3b mRNA was not expressed in Scn3b/ hearts.
Secondly, the Scn1b and Scn5a mRNA in both WT and Scn3b/
ventricles were expressed at higher levels compared to the
expression of Scn3b mRNA in WT hearts, conﬁrming a previous
report concerning such experiments in WT hearts (Marionneau
et al., 2005). Thirdly, Scn1bmRNAwas expressed at higher levels in
Scn3b/ hearts than in WT hearts. These levels of expression were
greater in the left than in the right ventricles in both WT and
Scn3b/ hearts. Finally, Scn5a mRNA was expressed at similar
levels in the left ventricles of WT and Scn3b/ hearts. It was
expressed at higher levels in the right ventricles of Scn3b/ hearts,
compared to levels in the right ventricles of WT hearts.
Electrophysiological studies in the ventricles of the whole intact
Scn3b/ hearts also showed arrhythmogenesis and conduction
abnormalities. This arrhythmogenesis took the form of either
monomorphic or polymorphic ventricular tachycardias (VTs). These
electrophysiological ﬁndings showed both similarities and
contrasts to earlier results obtained from experiments on arrhyth-
mogenicmurine Scn5aþ/, Scn5aþ/DKPQ,Kcne1/ and hypokalaemic
hearts, as well as human BrS (Table 9(A)). The murine systems had
been used to model human BrS, LQT3, LQT5 and hypokalaemia,
respectively (Balasubramaniam et al., 2003; Head et al., 2005;
Killeen et al., 2007; Papadatos et al., 2002). Firstly, the Scn3b/
hearts showed VT during programmed electrical stimulation (PES)
and paced electrogram fractionation analysis (PEFA) of these resultsdemonstrated abnormal conduction curves, in common with the
remaining examples in Table 9(A). These curves showed that
Scn3b/ hearts had electrogram duration (EGD) ratios that were
signiﬁcantly longer but conduction latencies that were similar at
the S1–S2 interval of 125 ms as those shown inWT hearts. Secondly,
the Scn3b/ hearts showed shorter ventricular effective refractory
periods (VERPs) than in WT hearts, in common with ﬁndings from
hypokalaemic hearts and clinical cases of BrS but in contrast to
features shown by the remaining murine models. Finally, Scn3b/
hearts had shorter endocardial and epicardial APD90 values than did
WT hearts. Nevertheless, the difference between these values in
Scn3b/ hearts, which offers a measure of the transmural gradient
of repolarization in the form of the DAPD90, was similar to that
shown by WT hearts. This is in common with ﬁndings in Scn5aþ/
hearts but in contrast to the remaining examples.
The use of the whole-cell patch-clamp technique demonstrated
the loss of function of the cardiac Naþ channel in ventricular
myocytes isolated from Scn3b/ hearts. These experiments were
carried out at the same temperature of 37 C as the studies used on
intact hearts in contrast to previous investigations that had carried
out similar single cell experiments at room temperature (Lopez-
Santiago et al., 2007; Papadatos et al., 2002). Table 9(B) compares
the resulting Naþ channel properties in Scn3b/ myocytes with
those shown in Scn5aþ/ and Scn5aþ/DKPQ myocytes and points to
a number of important comparisons. Firstly, Scn3b/ myocytes
showed signiﬁcantly smaller peak Naþ current densities, in
response to depolarizing voltage steps from a 100 mV holding
potential, than did WT myocytes. This was in common with
previous ﬁndings in Scn5aþ/ myocytes but in contrast to those
shown in Scn5aþ/DKPQ myocytes (Table 9(B)). This suggests
a reduced expression or proportion of functional Naþ channels in
the plasma membrane of Scn3b/ ventricles compared to that
shown in WT ventricles. The present experiments were performed
under conditions of higher ratios of extracellular and intracellular
[Naþ]. This may account for the larger Naþ current densities
observed in the present study, compared to those observed in
previous investigations (Nuyens et al., 2001; Papadatos et al., 2002).
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ratios of 2:1 and 2:2 respectively and carried out single cell
experiments at room temperature (22–23 C). Such conditions had
resulted in peak Naþ current densities of w15 pA/pF and
215 pA/pF respectively. Secondly, the Naþ channel activation
properties in Scn3b/ myocytes were similar to those of WT
myocytes in common with ﬁndings in Scn5aþ/ and Scn5aþ/DKPQ
myocytes. However, the present ﬁndings were obtained at a higher
temperature of 37 C than used in the previous studies (Lopez-
Santiago et al., 2007; Papadatos et al., 2002). This may account for
the similarly highly rapid time courses of activation and small slope
factors of steady-state activation observed in both the WT and
Scn3b/ myocytes. Thirdly, the position of the inactivation curves
in Scn3b/ myocytes was nevertheless shifted in the negative
direction relative to that shown in WT myocytes, whereas both
Scn5aþ/ and Scn5aþ/DKPQ myocytes showed normal inactivation
curves. At a typical resting membrane potential between 80 and
70mV (Guo et al., 1999; Remme et al., 2006; Yao et al., 1998), such
a shift would result in the inactivation of a further 10 to 37% of the
Naþ channels in Scn3b/myocytes, compared to that shown inWT
myocytes. Finally, the time course in the recovery from inactivation
in Scn3b/ myocytes were similar to that shown in WT myocytes
in common with ﬁndings in Scn5aþ/DKPQ myocytes.
Together, the altered peak Naþ current density and inactivation
features shown in Scn3b/ myocytes are compatible with
a reduction of the total in vivo Naþ current. This is compatible with
ﬁndings in BrS. Thus, although the clinical cases of BrS have shown
a wide range of alterations in the activation, inactivation and
recovery from inactivation properties, all show reduced Naþ
currents. The present ﬁndings also add a further example of BrS
that involves mutations in the Naþ channel b-subunit. A previous
investigation had identiﬁed a single mutation in the SCN1B gene
and twomutations in the splice variant of the same gene in patients
with BrS (Watanabe et al., 2008). It used a heterologous expression
system provided by Chinese hamster ovary (CHO) cells, to study the
consequent changes in the biophysical properties of the Naþ
channel resulting from the mutations. In agreement with the
present example, cells expressing both the WT Nav1.5 and such
mutant b-subunits showed signiﬁcantly reduced peak Naþ
currents. In contrast, activation and inactivation properties of the
Naþ channel shifted in the positive direction in relation to ﬁndings
in cells expressing WT Nav1.5 and WT b-subunits. The present
ﬁndings also complement other investigations in which alterations
in the b-subunit expression can produce other electrophysiological
changes that include a LQT-like phenotype. For example, Lopez-
Santiago et al. (2007) associated a deletion of the Scn1b gene in
a murine system with an increase in peak Naþ currents and QT
prolongation.
The present ﬁndings complement reports of altered Naþ
channel biophysical properties resulting from b3 expression in
heterologous expression systems by describing the consequences
of similar expression in vivo. However, the properties of such in
vitro expression systems may not correspond to features observed
in vivo and have demonstrated conﬂicting results despite the
transfection of identical sets of genes. Such systems lack func-
tionally important proteins such as ankyrin proteins that form
complexes with the Naþ channel in vivo (Abriel and Kass, 2005).
Thus, on the one hand, Xenopus oocytes injected with cRNA for
Nav1.5 and b3 subunits demonstrated signiﬁcantly larger peak
Naþ currents and positive shifts in the inactivation curves than in
cells expressing Nav1.5 only (Fahmi et al., 2001). In contrast, CHO
cells expressing Nav1.5 and b3 subunits resulted in similar peak
Naþ currents with negative shifts in the activation and inactiva-
tion curves compared to cells expressing Nav1.5 only (Ko et al.,
2005).In conclusion, we have for the ﬁrst time associated the lack of
the Scn3b gene with a ventricular arrhythmogenesis in intact
perfused hearts whose features are similar to those shown in
Scn5aþ/ hearts.
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